Table 1.

Review of the literature from 2007 to 2009.

AUTHORS	AGE AND SEX	SYMPHTOMS	DURATION	TREATMENT	RECURRENCE
Igren et Al	58 F	LBP + sciatica	17 yrs	GTR	no
Sonneland	32 M	LBP	7 mos	GTR	no
	62 M	LBP + sciatica	6 wks	GTR	no
	52 M	LBP	3 yrs	STR + RXT	recurrence after 9 yrs
	57 M	LBP + sciatica	7 yrs	STR	no
	67 F	LBP + sciatica	1 yr	GTR	no
	49 M	LBP + sciatica	6 yrs	GTR + RXT	no
	61 M	LBP + sciatica	14 mos	GTR	no
	47 F	LBP + sciatica	1 yrs	STR + RXT	recurrence after 1 yr
	50 M	LBP + sciatica	3 wks	GTR	no
	71 F	LBP + sciatica	7 yrs	GTR	no
	56 M	paraparesys	1 yrs	GTR	no
	52 F	LBP + sciatica	3 mos	GTR + RXT	no
	53 M	LBP + sciatica	2 yrs	GTR + RXT	no
	48 F	LBP + sciatica	3 yrs	GTR	no
	36 M	LBP	NS	GTR	no
	39 M	LBP	15 yrs	GTR	no
	48 M	LBP + sciatica	1,5 yrs	GTR	no
	40 F	LBP + sciatica	2 yrs	GTR	no
	50 F	LBP + sciatica	15 yrs	GTR	no
	59 M	LBP + sciatica	2 yrs	GTR	no
	58 F	LBP + sciatica	7 mos	GTR	no
	66 F	LBP + sciatica	many yrs	GTR	no
	62 F	LBP + sciatica	many mos	GTR	no
	39 F	LBP + sciatica	10 yrs	GTR + RXT	no
	30 F	LBP + sciatica	4,5 yrs	GTR	no
	69 F	claudicatio	1 yrs	GTR	no
Russel et Al	61 F	LBP	many yrs	GTR	no
	56 F	progressive paraplegia	10 days	GTR	no
Moran et Al	22 F	LBP	NS	GTR	no
	44 M	LBP	NS	GTR	no
Sousa et Al	51 M	LBP + sciatica	3 yrs	GTR	no
Landi et Al	49 M	sciatica + weakness at lower left limb	3 mos	GTR	no

Demographic aspects of previous 32 cases of paraganglioma of filum terminale, addicted with the our case.